1. Outcome of 8-hour dosing intervals with beta-lactam antibiotics in adult acute bacterial meningitis
- Author
-
Magnus Brink and Lars Hagberg
- Subjects
Adult ,Male ,Microbiology (medical) ,medicine.medical_specialty ,Adolescent ,medicine.drug_class ,Antibiotics ,Meningitis, Listeria ,Meningitis, Meningococcal ,beta-Lactams ,medicine.disease_cause ,Drug Administration Schedule ,Meningitis, Bacterial ,Listeria monocytogenes ,Internal medicine ,Streptococcus pneumoniae ,medicine ,Humans ,Dosing ,Aged ,Retrospective Studies ,Antibacterial agent ,Aged, 80 and over ,General Immunology and Microbiology ,Meningitis, Pneumococcal ,business.industry ,Mortality rate ,Incidence (epidemiology) ,General Medicine ,Middle Aged ,Anti-Bacterial Agents ,Surgery ,Community-Acquired Infections ,Treatment Outcome ,Infectious Diseases ,Etiology ,Female ,business - Abstract
The outcome of dosing with beta-lactam antibiotics at 8-h intervals for adult patients with community-acquired acute bacterial meningitis was retrospectively analysed at Sahlgrenska University Hospital, Gothenburg, Sweden. 80 medical records were identified for a 6-y period from 1999 to 2004. The most common pathogens noted were Streptococcus pneumoniae (47.5%), Neiseria meningitidis (12.5%), and Listeria monocytogenes (5.0%). Other bacteria were diagnosed in 16.3% of all episodes, but the bacteriological aetiology remained unknown in 18.8%. 79 episodes of bacterial meningitis were treated with beta-lactam antibiotics at 8-h dosing intervals. The mortality rate in these patients was 6.3%, with an incidence of permanent neurological deficiencies of 24.1%. Our study shows that a low mortality rate can be achieved using beta-lactam antibiotics at longer dosing intervals than usually recommended by international guidelines.
- Published
- 2006
- Full Text
- View/download PDF